Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days
  • Most recent
    • Best match

News

The Lancet5d
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
Copyright: © 2022 Elsevier Ltd. All rights reserved.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

To decide on Iran action
Section of I-40 closed
Announces retirement
DOJ cannot represent Trump
Places limits on ICE visits
Putin offers to broker deal
Kylian Mbappé hospitalized
Apologizes to victim's family
Announces bid for Congress
Chinese student sentenced
Erick makes landfall
Injured in car crash
New cannabis use study
Heat dome to blanket US
Break-in reported at home
Singer Lou Christie dies
NK fires multiple rockets
Hate crime case can proceed
Man charged in attack plot
USDA to open fly factory
Kids cough syrup recalled
Alleged trespasser charged
Robotaxi launch delay urged
Google hits setback
SpaceX rocket explodes
Microsoft plans job cuts
ISR hospital hit by missile
Extends ban deadline
NTSB issues safety warning
LGBTQ+ hotline to end
Announces 2026 Senate run
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy